ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

All Bruton's tyrosine kinase inhibitors have similar efficacy and risks: Commentary.

Özgür Yaldizli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.